H2O America (HTO) Q3 2025 Earnings Transcript

H2O America reported Q3 adjusted diluted EPS of $1.27, up 8%, and raised full-year 2025 adjusted EPS guidance to $2.95-$3.00 while reaffirming 5%-7% long-term EPS CAGR through 2029. Revenue rose 7% on rate increases and pass-through costs, and the company has spent $358 million year-to-date on infrastructure, 74% of its revised $486 million capex plan. Regulatory progress in Connecticut, Maine, and Texas, plus ongoing Quadvest/Cibolo Valley acquisition plans, support the growth outlook despite higher expenses, taxes, and dilution.

Analysis

HTO is quietly de-risking the equity story: the business now looks less like a rate-case lottery and more like a regulated compounder with multiple self-funding levers. The important second-order effect is that management is demonstrating it can keep the growth engine running even before the Texas acquisition closes, which reduces the market’s dependence on M&A as the sole source of upside. That matters because the stock is likely being discounted for a perceived “deal-or-bust” path; the call argues the base case is still constructive without it.

The bigger near-term issue is not execution, but capital structure sequencing. A company that is funding heavy CapEx, supporting long-duration utility asset growth, and preparing for a large Texas transaction is exposed to a valuation gap if equity markets stay weak into the financing window. That creates a hidden risk: even if the regulatory process goes smoothly, a soft share price could force a more expensive mix of debt or partner equity, compressing the deal’s incremental accretion and muting multiple expansion.

The contrarian setup is that the market may be underestimating how valuable the recurring, formulaic rate recovery has become relative to acquisition optionality. The Texas connection growth gives management a credible path to organic expansion, while the financing costs are trending down on revolvers and fixed debt remains manageable. If investor skepticism is focused on the Aquarion overhang, the more important catalyst may be the year-end refresh of CapEx and long-term guidance, which can re-anchor the earnings trajectory and remove ambiguity around post-Quadvest economics.

Key Decisions for Investors

• Long HTO into the year-end guidance refresh (2-6 week horizon): best risk/reward if management confirms 2026-2029 EPS visibility; use a stop if the long-term growth reset disappoints or if financing mix turns more dilutive than expected.
• Buy HTO calls or call spreads around the expected December/January FMV disclosure: the catalyst is not the valuation itself, but reduced uncertainty on equity needs and deal accretion; upside should be sharp if the implied financing burden is lighter than feared.
• Pair trade: long HTO / short a higher-multiple regulated utility with larger acquisition dependence over the next 1-2 quarters; HTO’s organic growth and formula recovery should outperform if the market punishes deal-execution risk across the sector.
• If seeking lower-risk exposure, sell downside puts on HTO rather than buying outright: the thesis is supported by embedded rate recovery and CapEx visibility, while volatility is likely elevated until the STM filing and financing plan are clearer.